Back
Pieris Pharmaceuticals Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
45
PIRS
Pieris Pharmaceuticals
Last Price:
17.00
Seasonality Move:
9.58%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- The current trend is moderately bullish and PIRS is experiencing slight selling pressure.
Pieris Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.01 | Sell |
| 20-day SMA: | 16.76 | Buy |
| 50-day SMA: | 16.86 | Buy |
| 200-day SMA: | 13.67 | Buy |
| 8-day EMA: | 16.99 | Buy |
| 20-day EMA: | 16.84 | Buy |
| 50-day EMA: | 16.41 | Buy |
| 200-day EMA: | 17.6 | Sell |
Pieris Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 53.98 | Buy |
| Chaikin Money Flow: | -5122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.31 - 17.01) | Buy |
| Bollinger Bands (100): | (10.79 - 18.43) | Buy |
Pieris Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Pieris Pharmaceuticals Stock
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 17.00 while PIRS 8-day simple moving average is 17.01, which is a Sell signal.
- The stock price of PIRS is 17.00 while Pieris Pharmaceuticals 20-day SMA is 16.76, which makes it a Buy.
- Pieris Pharmaceuticals 50-day simple moving average is 16.86 while PIRS share price is 17.00, making it a Buy technically.
- PIRS stock price is 17.00 and Pieris Pharmaceuticals 200-day simple moving average is 13.67, creating a Buy signal.
PIRS Technical Analysis vs Fundamental Analysis
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy or a Sell?
-
Pieris Pharmaceuticals stock is rated a Sell
The current Pieris Pharmaceuticals [PIRS] share price is $17.00. The Score for PIRS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Pieris Pharmaceuticals Stock Info
Market Cap:
22.44M
Price in USD:
17.00
Share Volume:
14.23K
Pieris Pharmaceuticals 52-Week Range
52-Week High:
23.20
52-Week Low:
6.20
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Pieris Pharmaceuticals Share Price Forecast
-
What is the Pieris Pharmaceuticals stock price today?
The Pieris Pharmaceuticals stock price is 17.00 USD today. -
Will PIRS stock go up or go down?
Pieris Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Pieris Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pieris Pharmaceuticals is overvalued.
Is Pieris Pharmaceuticals Stock a Buy?
- Pieris Pharmaceuticals share price is 17.00 while PIRS 8-day exponential moving average is 16.99, which is a Buy signal.
- The stock price of PIRS is 17.00 while Pieris Pharmaceuticals 20-day EMA is 16.84, which makes it a Buy.
- Pieris Pharmaceuticals 50-day exponential moving average is 16.41 while PIRS share price is 17.00, making it a Buy technically.
- PIRS stock price is 17.00 and Pieris Pharmaceuticals 200-day simple moving average is 17.60, creating a Sell signal.
Fundamental Analysis of Pieris Pharmaceuticals
Is Pieris Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Technical Analysis of Pieris Pharmaceuticals
Should I short Pieris Pharmaceuticals stock?
- PIRS Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Pieris Pharmaceuticals is a Buy
- Pieris Pharmaceuticals Relative Strength Index (RSI) is 53.98, which suggest Pieris Pharmaceuticals is overbought
- The Bollinger Bands (25) for Pieris Pharmaceuticals is (16.31 - 17.01), which suggest Pieris Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Pieris Pharmaceuticals is (10.79 - 18.43), which suggest Pieris Pharmaceuticals is a Buy
* Pieris Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.